End-of-day quote
Shanghai S.E.
06:00:00 2024-04-25 pm EDT
|
5-day change
|
1st Jan Change
|
10.59
CNY
|
+4.03%
|
|
+5.58%
|
-2.22%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
25,730
|
26,999
|
22,161
|
18,210
|
21,483
|
20,987
|
-
|
-
|
Enterprise Value (EV)
1 |
25,487
|
26,406
|
21,296
|
17,422
|
20,528
|
18,802
|
19,121
|
17,792
|
P/E ratio
|
31.6
x
|
29.1
x
|
17.1
x
|
11.6
x
|
18.4
x
|
16.3
x
|
14
x
|
13.1
x
|
Yield
|
1.58%
|
1.57%
|
2.74%
|
2.72%
|
2.31%
|
2.29%
|
2.5%
|
2.22%
|
Capitalization / Revenue
|
9.26
x
|
9.34
x
|
6.78
x
|
6.55
x
|
6.99
x
|
6.13
x
|
5.4
x
|
4.84
x
|
EV / Revenue
|
9.18
x
|
9.13
x
|
6.52
x
|
6.27
x
|
6.67
x
|
5.49
x
|
4.92
x
|
4.1
x
|
EV / EBITDA
|
22.7
x
|
19.8
x
|
12.6
x
|
8.88
x
|
-
|
11.3
x
|
9.82
x
|
8.5
x
|
EV / FCF
|
29,668,309
x
|
36,984,384
x
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
5.15
x
|
4.9
x
|
3.59
x
|
2.8
x
|
2.99
x
|
2.67
x
|
2.35
x
|
2.06
x
|
Nbr of stocks (in thousands)
|
2,033,989
|
2,017,889
|
2,021,989
|
1,983,679
|
1,983,617
|
1,981,734
|
-
|
-
|
Reference price
2 |
12.65
|
13.38
|
10.96
|
9.180
|
10.83
|
10.59
|
10.59
|
10.59
|
Announcement Date
|
4/14/20
|
1/14/21
|
1/24/22
|
2/6/23
|
1/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,777
|
2,892
|
3,268
|
2,778
|
3,075
|
3,426
|
3,888
|
4,340
|
EBITDA
1 |
1,121
|
1,335
|
1,693
|
1,963
|
-
|
1,663
|
1,947
|
2,092
|
EBIT
1 |
967.8
|
1,181
|
1,549
|
1,829
|
1,365
|
1,501
|
1,752
|
1,891
|
Operating Margin
|
34.85%
|
40.82%
|
47.41%
|
65.82%
|
44.39%
|
43.8%
|
45.07%
|
43.57%
|
Earnings before Tax (EBT)
1 |
952.5
|
1,108
|
1,534
|
1,830
|
1,366
|
1,503
|
1,754
|
1,896
|
Net income
1 |
811.2
|
929.9
|
1,308
|
1,582
|
1,168
|
1,299
|
1,507
|
1,623
|
Net margin
|
29.21%
|
32.15%
|
40.03%
|
56.93%
|
37.97%
|
37.91%
|
38.76%
|
37.39%
|
EPS
2 |
0.4000
|
0.4600
|
0.6400
|
0.7900
|
0.5900
|
0.6500
|
0.7543
|
0.8100
|
Free Cash Flow
|
859.1
|
714
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
30.93%
|
24.69%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
76.65%
|
53.47%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
105.9%
|
76.78%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.2000
|
0.2100
|
0.3000
|
0.2500
|
0.2500
|
0.2425
|
0.2650
|
0.2350
|
Announcement Date
|
4/14/20
|
1/14/21
|
1/24/22
|
2/6/23
|
1/29/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
812.9
|
887.5
|
500
|
711.5
|
679.4
|
665.4
|
701
|
725.2
|
983.9
|
591.4
|
751.1
|
875
|
855
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
289.5
|
980.4
|
403.4
|
259.4
|
185.7
|
289.6
|
272.9
|
316.5
|
486.1
|
238.9
|
291.5
|
354.2
|
361.7
|
Operating Margin
|
35.61%
|
110.47%
|
80.67%
|
36.46%
|
27.33%
|
43.53%
|
38.93%
|
43.65%
|
49.4%
|
40.39%
|
38.81%
|
40.48%
|
42.31%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
214.7
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
36.3%
|
-
|
-
|
-
|
EPS
2 |
0.1200
|
0.4100
|
0.1800
|
0.1100
|
0.0900
|
0.1300
|
0.1100
|
0.1400
|
0.2100
|
0.1100
|
0.1450
|
0.1600
|
0.1800
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
1/24/22
|
4/28/22
|
8/30/22
|
10/30/22
|
2/6/23
|
4/26/23
|
8/21/23
|
10/30/23
|
1/29/24
|
4/27/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
243
|
593
|
865
|
788
|
954
|
2,184
|
1,865
|
3,195
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
859
|
714
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
16.6%
|
17.7%
|
22.1%
|
24.5%
|
17.1%
|
17.2%
|
17.7%
|
16.5%
|
ROA (Net income/ Total Assets)
|
15%
|
16.8%
|
21.6%
|
23.8%
|
-
|
16.4%
|
16.8%
|
15.9%
|
Assets
1 |
5,407
|
5,532
|
6,062
|
6,635
|
-
|
7,935
|
8,996
|
10,219
|
Book Value Per Share
2 |
2.460
|
2.730
|
3.060
|
3.280
|
3.620
|
3.970
|
4.510
|
5.140
|
Cash Flow per Share
2 |
0.5700
|
0.5900
|
0.5600
|
0.4300
|
0.4300
|
0.6400
|
0.8000
|
0.8700
|
Capex
1 |
293
|
478
|
580
|
492
|
348
|
266
|
315
|
452
|
Capex / Sales
|
10.55%
|
16.54%
|
17.76%
|
17.69%
|
11.31%
|
7.77%
|
8.1%
|
10.41%
|
Announcement Date
|
4/14/20
|
1/14/21
|
1/24/22
|
2/6/23
|
1/29/24
|
-
|
-
|
-
|
Last Close Price
10.59
CNY Average target price
15.27
CNY Spread / Average Target +44.22% Consensus |
1st Jan change
|
Capi.
|
---|
| -2.22% | 2.9B | | -4.68% | 86.13B | | +1.32% | 39.82B | | -19.27% | 30.42B | | +57.86% | 25.23B | | -16.09% | 15.36B | | -9.14% | 11.95B | | -17.69% | 11.6B | | -43.00% | 11.51B | | +5.24% | 8.71B |
Biopharmaceuticals
|